Ismail Güderer

Ismail Güderer

Auto-generated profile, based on publicly available information

Ismail Güderer

Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) Jena Germany

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2022 in Pharmaceutical Development and Technology
Verified
Journal Article
Closed access
SASema Arisoy
Sema Arisoy
MKMeryem Kocas
Meryem Kocas
TCTansel Comoglu
Tansel Comoglu
IGIsmail Guderer
Ismail Guderer
SBSreeparna Banerjee
Sreeparna Banerjee
SARS-CoV-2 is a novel coronavirus with a positively oriented single-stranded RNA that first appeared in December 2019. In this study, Angiotensin Converting Enzyme 2 (ACE2) loaded decoy liposomes were developed and characterized. ACE2 protein was loaded onto a liposomal carrier system and its toxicity and effectiveness were evaluated in cell culture and in vitro virus neutralization studies. Liposomes were prepared with the film hydration method and adjusted for size with the dialysis membrane method or the ultrasonic homogenization method. All formulations showed high entrapment efficiency between 99.98–79.6%. Liposomes with two different particle sizes above 2 µm and below 500 nm were obtained with the dialysis membrane method and homogenization method. Two optimum formulations, M6-S90 with a PDI value of 0.383 ± 0.053 and particle size of 397.7 ± 28.25 nm which was produced by ultrasonic homogenization and M6-4 with a PDI 0.769 ± 0.205 and particle size of 2606 ± 1396.00 were chosen as optimum formulations for further studies. M6-S90 was stable and showed low toxicity on Calu3 lung epithelial cells. Pre-incubation of M6-S90 with with 3.1 × 105 PFU/mL of SARS-CoV-2 followed by incubation with Vero E6 cells resulted in a 4 log fold change reduction in cell death compared to virus alone. This suggests that MS6-S90 had good neutralization activity on SARS-CoV-2 whilst maintaining viability of the host cell. The novel ACE-2 loaded decoy liposomes described in this study can be further evaluated for the treatment of COVID-19.

22 January 2024 in Translational Oncology
Verified
Journal Article
Open access
HHH. Hazal Hüsnügil
H. Hazal Hüsnügil
ATAliye Ezgi Güleç Taşkıran
Aliye Ezgi Güleç Taşkıran
IGIsmail Güderer
Ismail Güderer
LNLeman Nur Nehri
Leman Nur Nehri
GOGöksu Oral
Göksu Oral
SBSreeparna Banerjee
Sreeparna Banerjee
Nutrient restriction in cancer cells can activate a number of stress response pathways for cell survival. We aimed to determine mechanistically how nutrient depletion in colorectal cancer (CRC) cells leads to cellular adaptation. Cell survival under nutrient depletion (ND) was evaluated by colony formation and in vivo tumor formation assays. Lysosomes are activated with ND; therefore, we incubated the ND cells with the V-ATPase inhibitor Bafilomycin A1 (ND+Baf). The expression of epithelial and mesenchymal markers with ND+Baf was determined by RNA sequencing and RT-qPCR while motility was determined with an in vivo Chorioallantoic membrane (CAM) assay. Reorganization of cytoskeletal network and lysosomal positioning was determined by immunocytochemistry. 4 different colorectal cancer (CRC) cell lines under ND showed high viability, tumor forming ability and increased expression of one or more epithelial and mesenchymal markers, suggesting the activation of partial (p)-EMT. We observed a further increase in p-EMT markers, numerous membrane protrusions, decreased cell-cell adhesion in 3D, and increased motility in ND+Baf cells. The protrusions in the ND+Baf cells were primarily mediated by microtubules and enabled the relocalization of lysosomes from the perinuclear region to the periphery. ND activated p-EMT in CRC cells, which was exacerbated by lysosomal alkalinization. The ND+Baf cells also showed numerous protrusions containing lysosomes, which may lead to lysosomal exocytosis and enhanced motility.

10 September 2024 in Journal of Molecular Structure
Verified
Journal Article
Closed access
MUMehmet Burak Uzun
Mehmet Burak Uzun
IGİsMail Guderer
İsMail Guderer
SBSreeparna Banerjee
Sreeparna Banerjee
AYAyşen YILMAZ
Ayşen YILMAZ

1 June 2019 in Atlas of Genetics and Cytogenetics in Oncology and Haematology
Verified
Journal Article
Closed access
PDF file
ESEsin Gülce Seza
Esin Gülce Seza
IGIsmail Güderer
Ismail Güderer
ÇEÇagdas Ermis
Çagdas Ermis
SBSreeparna Banerjee
Sreeparna Banerjee

26 June 2026 in FEBS Letters
Verified
Journal Article
Open access
PDF file
MOMark Olenik
Mark Olenik
IGİsMail Güderer
İsMail Güderer
YWYi Wang
Yi Wang
TATayyaba Alvi
Tayyaba Alvi
PPPrasoon Pandey
Prasoon Pandey
HDHandan Melike Dönertaş
Handan Melike Dönertaş
The gut microbiome changes systematically with age and associates with age‐related morbidity and mortality, establishing it as a candidate biomarker and intervention target for ageing. Realising this potential requires methodological rigour, as distinguishing genuine biological signals from methodological artefacts remains challenging given variable findings across cohorts. This review provides an integrated framework for human microbiome‐ageing research, organised around five methodological challenges that will collectively strengthen causal inference. We examine how age‐associated factors can correlate with chronological age and may confound the microbiome‐age associations, while selection biases shape old‐age cohorts towards healthier profiles. We address within‐host temporal dynamics and between‐individual heterogeneity that require appropriate sampling to distinguish age‐related signatures from transient states, and validation strategies that separate ageing from batch effects in predictive models. Mendelian randomisation provides causal leverage when triangulated with longitudinal and interventional evidence. Throughout, we examine how design choices determine the limits of analytical inference. The review concludes with a practical checklist, equipping researchers to strengthen reproducibility, improve generalisability and advance microbiome‐based metrics towards validated indicators of biological ageing.